DUBLIN–(BUSINESS WIRE)–The “Global Bioreactors Market (2022-2027) by Product Type, Cell, Molecule, Usage, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Bioreactors Market is estimated to be USD 1.66 Bn in 2022 and is expected to reach USD 2.68 Bn by 2027, growing at a CAGR of 10.06%.
Market Segmentations
The Global Bioreactors Market is segmented based on Product Type, Cell, Molecule, Usage, End-User, and Geography.
By Product Type, the market is classified into Single-use and Reusable.
By Cell, the market is classified into Mammalian Cells, Bacterial Cells, Yeast Cells, and Others.
By Molecule, the market is classified into Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others.
By Usage, the market is classified into Developmental, Pre-Clinical & Clinical, and Commercial Production.
By End-User, the market is classified into R&D Organizations, Biopharmaceutical Manufacturers, and Contract Manufacturing Organizations (CMO).
By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.
Market Dynamics
Drivers
Rapid Growth of the Biopharmaceuticals and Biologics Industry
Technology Advancements in Bioreactors
Adoption of Single-Use Bioreactors (Subs) and Hybrid Bioreactors
Increasing Demand for Personalized Medicine
Restraints
Low Capacity of Single-Use Bioreactor or Disposable Bioreactor
Concerns Regarding Extrables and Leachables
Opportunities
High Market Potential in Emerging Economies
Rising Demand for Personalized Medicine
Challenges
Stringent Regulatory Framework
Countries Studied
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Report Highlights:
A complete analysis of the market, including the parent industry
Important market dynamics and trends
Market segmentation
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Bioreactors Market, By Product Type
7 Global Bioreactors Market, By Cell
8 Global Bioreactors Market, By Molecule
9 Global Bioreactors Market, By Usage
10 Global Bioreactors Market, By End-User
11 Americas’ Bioreactors Market
12 Europe’s Bioreactors Market
13 Middle East and Africa’s Bioreactors Market
14 APAC’s Bioreactors Market
15 Competitive Landscape
16 Company Profiles
17 Appendix
Companies Mentioned
3D Biotek LLC
Applikon Biotechnology BV
BBI-Biotech GmbH
Bioengineering AG
Broadley-James Corp.
Cell Culture Company
Cytiva
Eppendorf AG
GEA Group AG
Infors AG
Merck KGaA
Pall Corp.
Pierre Guerin SAS
Praj Hipurity Systems Ltd.
Sartorius AG
Solaris Biotechnology S.r.l
Solida Biotech GmBH
Thermo Fisher Scientific Inc.
ZETA Holding GmbH
For more information about this report visit https://www.researchandmarkets.com/r/sgi6mi
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
